Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2019 Filed Sep 9, 2019 21:50 UTC |
HERTIA JOHNExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 2,400 | $119.54 | $286,896.00 |
DisclosureSEC source: 0001652252-19-000051 · edgar.xml · nonDerivative · entry 3 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 21:36 UTC |
TUMOLO ANNETTEExecutive Vice President
|
SaleBio-Rad A Common Stock | 371 | $340.00 | $126,140.00 |
DisclosureSEC source: 0001652252-19-000049 · edgar.xml · nonDerivative · entry 3 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,917.3476 Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 21:50 UTC |
HERTIA JOHNExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000051 · edgar.xml · derivative · entry 17 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F8 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. F8 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 21:50 UTC |
HERTIA JOHNExecutive Vice President
|
Tax withholdingBio-Rad A Common Stock | 208 | $339.48 | $70,611.84 |
DisclosureSEC source: 0001652252-19-000051 · edgar.xml · nonDerivative · entry 2 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,299 Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 21:50 UTC |
HERTIA JOHNExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000051 · edgar.xml · nonDerivative · entry 1 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 22:11 UTC |
HUTTON RONALD WVice President and Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 180 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000053 · edgar.xml · derivative · entry 5 HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540 Underlying: Bio-Rad A Common Stock · 180 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 22:11 UTC |
HUTTON RONALD WVice President and Treasurer
|
Tax withholdingBio-Rad A Common Stock | 63 | $339.48 | $21,387.24 |
DisclosureSEC source: 0001652252-19-000053 · edgar.xml · nonDerivative · entry 2 HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,259.9448 Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 22:11 UTC |
HUTTON RONALD WVice President and Treasurer
|
Exercise / conversionBio-Rad A Common Stock | 180 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000053 · edgar.xml · nonDerivative · entry 1 HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,322.9448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 21:36 UTC |
TUMOLO ANNETTEExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000049 · edgar.xml · derivative · entry 6 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 21:36 UTC |
TUMOLO ANNETTEExecutive Vice President
|
Tax withholdingBio-Rad A Common Stock | 208 | $339.48 | $70,611.84 |
DisclosureSEC source: 0001652252-19-000049 · edgar.xml · nonDerivative · entry 2 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,288.3476 Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 21:36 UTC |
TUMOLO ANNETTEExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000049 · edgar.xml · nonDerivative · entry 1 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,496.3476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 21:17 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000047 · edgar.xml · derivative · entry 5 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 21:17 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Tax withholdingBio-Rad A Common Stock | 208 | $339.48 | $70,611.84 |
DisclosureSEC source: 0001652252-19-000047 · edgar.xml · nonDerivative · entry 2 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,795 Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 21:17 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000047 · edgar.xml · nonDerivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 21:08 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000045 · edgar.xml · derivative · entry 5 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Bio-Rad A Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 21:08 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Tax withholdingBio-Rad A Common Stock | 173 | $339.48 | $58,730.04 |
DisclosureSEC source: 0001652252-19-000045 · edgar.xml · nonDerivative · entry 2 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756.9692 Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 21:08 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000045 · edgar.xml · nonDerivative · entry 1 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 929.9692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 19:49 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 2,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000043 · edgar.xml · derivative · entry 6 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Bio-Rad A Common Stock · 2,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 19:49 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 1,290 | $339.48 | $437,929.20 |
DisclosureSEC source: 0001652252-19-000043 · edgar.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,182 Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 19:49 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000043 · edgar.xml · nonDerivative · entry 1 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 19:45 UTC |
STARK JAMES RVP, Corporate Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000041 · edgar.xml · derivative · entry 5 STARK JAMES R · CIK 0001248083 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 Underlying: Bio-Rad A Common Stock · 300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 19:45 UTC |
STARK JAMES RVP, Corporate Controller
|
Tax withholdingBio-Rad A Common Stock | 104 | $339.48 | $35,305.92 |
DisclosureSEC source: 0001652252-19-000041 · edgar.xml · nonDerivative · entry 2 STARK JAMES R · CIK 0001248083 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326 Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 19:45 UTC |
STARK JAMES RVP, Corporate Controller
|
Exercise / conversionBio-Rad A Common Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000041 · edgar.xml · nonDerivative · entry 1 STARK JAMES R · CIK 0001248083 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 19:40 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000039 · edgar.xml · derivative · entry 3 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Bio-Rad A Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 19:40 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
Tax withholdingBio-Rad A Common Stock | 248 | $339.48 | $84,191.04 |
DisclosureSEC source: 0001652252-19-000039 · edgar.xml · nonDerivative · entry 2 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,163 Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 19:40 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
Exercise / conversionBio-Rad A Common Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000039 · edgar.xml · nonDerivative · entry 1 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 21:26 UTC |
HERTIA JOHNExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000037 · edgar.xml · derivative · entry 4 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 21:26 UTC |
HERTIA JOHNExecutive Vice President
|
Tax withholdingBio-Rad A Common Stock | 208 | $335.20 | $69,721.60 |
DisclosureSEC source: 0001652252-19-000037 · edgar.xml · nonDerivative · entry 2 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,907 Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 21:26 UTC |
HERTIA JOHNExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000037 · edgar.xml · nonDerivative · entry 1 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:07 UTC |
HUTTON RONALD WVice President and Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 180 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000024 · edgar.xml · derivative · entry 4 HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720 Underlying: Bio-Rad A Common Stock · 180 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:07 UTC |
HUTTON RONALD WVice President and Treasurer
|
Tax withholdingBio-Rad A Common Stock | 63 | $335.20 | $21,117.60 |
DisclosureSEC source: 0001652252-19-000024 · edgar.xml · nonDerivative · entry 2 HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,142.9448 Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:07 UTC |
HUTTON RONALD WVice President and Treasurer
|
Exercise / conversionBio-Rad A Common Stock | 180 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000024 · edgar.xml · nonDerivative · entry 1 HUTTON RONALD W · CIK 0001248073 · Vice President and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,205.9448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 6.3045, 6.7317, 7.9962 and 5.2888 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 9/28/18, 12/31/18, 3/29/19 and 6/28/19, respectively. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:52 UTC |
TUMOLO ANNETTEExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000035 · edgar.xml · derivative · entry 5 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:52 UTC |
TUMOLO ANNETTEExecutive Vice President
|
Tax withholdingBio-Rad A Common Stock | 208 | $335.20 | $69,721.60 |
DisclosureSEC source: 0001652252-19-000035 · edgar.xml · nonDerivative · entry 2 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,896.3476 Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:52 UTC |
TUMOLO ANNETTEExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000035 · edgar.xml · nonDerivative · entry 1 TUMOLO ANNETTE · CIK 0001717996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,104.3476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:22 UTC |
STARK JAMES RVP, Corporate Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000030 · edgar.xml · derivative · entry 4 STARK JAMES R · CIK 0001248083 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Underlying: Bio-Rad A Common Stock · 200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:22 UTC |
STARK JAMES RVP, Corporate Controller
|
Tax withholdingBio-Rad A Common Stock | 70 | $335.20 | $23,464.00 |
DisclosureSEC source: 0001652252-19-000030 · edgar.xml · nonDerivative · entry 2 STARK JAMES R · CIK 0001248083 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130 Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:22 UTC |
STARK JAMES RVP, Corporate Controller
|
Exercise / conversionBio-Rad A Common Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000030 · edgar.xml · nonDerivative · entry 1 STARK JAMES R · CIK 0001248083 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:17 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 2,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000028 · edgar.xml · derivative · entry 8 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Underlying: Bio-Rad A Common Stock · 2,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. F7 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:17 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President and CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 1,290 | $335.20 | $432,408.00 |
DisclosureSEC source: 0001652252-19-000028 · edgar.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,872 Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:17 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President and CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000028 · edgar.xml · nonDerivative · entry 1 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:11 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000026 · edgar.xml · derivative · entry 5 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Bio-Rad A Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:11 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
Tax withholdingBio-Rad A Common Stock | 206 | $335.20 | $69,051.20 |
DisclosureSEC source: 0001652252-19-000026 · edgar.xml · nonDerivative · entry 2 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,911 Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:11 UTC |
Magni GiovanniEVP, Chief Strategy Officer
|
Exercise / conversionBio-Rad A Common Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000026 · edgar.xml · nonDerivative · entry 1 Magni Giovanni · CIK 0001292816 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:04 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000022 · edgar.xml · derivative · entry 5 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Bio-Rad A Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:04 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Tax withholdingBio-Rad A Common Stock | 173 | $335.20 | $57,989.60 |
DisclosureSEC source: 0001652252-19-000022 · edgar.xml · nonDerivative · entry 2 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429.9692 Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:04 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000022 · edgar.xml · nonDerivative · entry 1 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 602.9692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:00 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000020 · edgar.xml · derivative · entry 6 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 4, 2019. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:00 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Tax withholdingBio-Rad A Common Stock | 208 | $335.20 | $69,721.60 |
DisclosureSEC source: 0001652252-19-000020 · edgar.xml · nonDerivative · entry 3 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,403 Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:00 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-19-000020 · edgar.xml · nonDerivative · entry 2 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.